Sponsor
Frank Pallone
Representative · D-NJ
Representative · D-NJ
The bill tightens border enforcement to keep falsely marketed dietary supplements out of the U.S., protecting consumers and honest firms, but raises compliance burdens and seizure risk that could hit importers, distributors, and small supplement businesses.
Consumers are better protected because products falsely marketed as dietary supplements can be refused at the border or seized, reducing the chance unsafe or mislabeled products enter the U.S. market.
Legitimate supplement companies face less unfair competition because products made with involvement of debarred persons can be barred from importation, helping compliant small businesses compete fairly.
Customs and FDA enforcement gets clearer statutory authority to refuse or seize these products, reducing procedural ambiguity and likely improving consistent enforcement.
Importers and small supplement businesses may face higher compliance costs and more frequent shipment refusals at the border, raising operating costs and disrupting supply chains.
Products could be seized or detained based on marketing claims even if they are otherwise safe, causing inventory loss, cash-flow disruption, and legal costs for sellers and potentially taxpayers if disputes are prolonged.
A debarment-based prohibition may extend penalties to distributors or sellers who relied on third-party manufacturers, increasing regulatory risk for businesses that do not directly employ debarred persons.
Based on analysis of 2 sections of legislative text.
Makes it illegal to sell or import products marketed as dietary supplements that don't meet the legal definition or were produced with involvement from debarred persons; allows border refusal and seizure.
Official title: To amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.
Introduced February 5, 2026 by Frank Pallone · Last progress February 5, 2026
Creates two new federal prohibitions: (1) bans introducing into interstate commerce any product marketed as a dietary supplement that does not meet the statutory definition of “dietary supplement,” and (2) bans introducing dietary supplements prepared, packed, or held with the assistance or direction of a person debarred under existing FDA debarment law. It also makes such products subject to refusal of admission at the border and authorizes seizure/condemnation for enforcement.